The Combined Empagliflozin and Sacubitril/Valsartan Therapy Attenuates Isoproterenol-Induced Heart Failure in Rats: Functional, Molecular, and Structural Insights
- DOI
- 10.1007/s10557-025-07675-4
- Published
- 2025-02-06
- Container
- Cardiovascular Drugs and Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10557-025-07675-4,
title = {The Combined Empagliflozin and Sacubitril/Valsartan Therapy Attenuates Isoproterenol-Induced Heart Failure in Rats: Functional, Molecular, and Structural Insights},
author = {Maja Muric and Ivan Srejovic and Jovana Novakovic and Vladimir Zivkovic and Jovana Joksimovic Jovic and Jasmina Sretenovic and Marina Nikolic and Nevena Lazarevic and Marijana Andjic and Aleksandar Kocovic and Jovana Jakovljevic Uzelac and Sergey Bolevich and Vladimir Jakovljevic},
year = {2025},
journal = {Cardiovascular Drugs and Therapy},
doi = {10.1007/s10557-025-07675-4},
url = {https://doi.org/10.1007/s10557-025-07675-4}
}RIS
TY - JOUR TI - The Combined Empagliflozin and Sacubitril/Valsartan Therapy Attenuates Isoproterenol-Induced Heart Failure in Rats: Functional, Molecular, and Structural Insights AU - Maja Muric AU - Ivan Srejovic AU - Jovana Novakovic AU - Vladimir Zivkovic AU - Jovana Joksimovic Jovic AU - Jasmina Sretenovic AU - Marina Nikolic AU - Nevena Lazarevic AU - Marijana Andjic AU - Aleksandar Kocovic AU - Jovana Jakovljevic Uzelac AU - Sergey Bolevich AU - Vladimir Jakovljevic PY - 2025 JO - Cardiovascular Drugs and Therapy DO - 10.1007/s10557-025-07675-4 UR - https://doi.org/10.1007/s10557-025-07675-4 ER -
APA
Muric, M., Srejovic, I., Novakovic, J., Zivkovic, V., Jovic, J. J., Sretenovic, J., Nikolic, M., Lazarevic, N., Andjic, M., Kocovic, A., Uzelac, J. J., Bolevich, S., & Jakovljevic, V. (2025). The Combined Empagliflozin and Sacubitril/Valsartan Therapy Attenuates Isoproterenol-Induced Heart Failure in Rats: Functional, Molecular, and Structural Insights. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-025-07675-4
Source records
- crossref · retrieved 2026-09-26T04:16:05.944Z